Project Grant R01MH133268

Award Date 5/17/24
Completion Date 3/31/29
Dollars Obligated $843K
Federal Grant Program
93.242
Assistance Type
Project Grant
Place of Performance
Belmont, MA 02478, USA
Similar Awards
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $5,596,529 project grant to the Icahn School of Medicine at Mount Sinai to conduct research on understanding the interactions between gene X and stress across different brain cell types in post-traumatic stress disorder (PTSD). This 4-year grant, awarded on Sep 30, 2023, will fund studies to establish a human induced pluripotent stem cell-based platform for testing the functional...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $435,426 to investigate sleep-related risk factors and underlying mechanisms for post-traumatic stress disorder (PTSD). The study aims to: 1) identify individuals with a trait susceptibility to acute sleep disturbances after trauma, and 2) determine the mechanisms by which these sleep disturbances predict PTSD. The research will leverage data...
This Project Grant award from the National Institute of Mental Health (NIMH) under CFDA program 93.242 (Mental Health Research Grants) provides $617,737 to support research investigating a thalamic-hippocampal pathway involved in contextual fear suppression and extinction. The University of Chicago, the grant recipient, will use advanced techniques like 2-photon microscopy and optogenetics to study how the nucleus reuniens region of the thalamus interacts with the hippocampus to regulate the...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $107,948 to Trustees of Boston University to conduct research on the role of neuroinflammation in post-traumatic stress disorder (PTSD) and chronic traumatic encephalopathy (CTE). The award will fund histological, genomic, and clinical data analysis to investigate...
The National Institute of Mental Health (NIMH) awarded a 5-year, $1,072,702 Project Grant under the Mental Health Research Grants program (CFDA 93.242) to the University of Vermont & State Agricultural College to investigate the neural substrates underlying higher-order fear memories. The research aims to use chemogenetic and electrophysiological techniques in freely moving rats to elucidate the cortical network signal properties that encode and retrieve higher-order conditioned fear...
This federal Project Grant award, with ID K23MH137459, was provided by the National Institute of Mental Health (NIMH) under its Mental Health Research Grants program (CFDA 93.242). The $179,002 award supports a 5-year research project to conduct a multilevel characterization of sensory cortical disinhibition and its impacts on neural networks and the phenomenological experience of trauma-related intrusive memories. The project, led by The McLean Hospital Corporation, will utilize magnetic...
This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), aims to develop and evaluate a novel digital therapeutic for adults with post-traumatic stress disorder (PTSD). The $440,092 award to OUI Therapeutics Inc. in New Haven, CT will fund the development of a mobile app called OTX-601, as well as a pilot randomized controlled trial to assess its feasibility, acceptability, usability, and preliminary efficacy...
This $1,413,000 Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) supports research at Arizona State University to develop a novel Genetics, Epigenetics, Adverse Experiences, and Neurobiology (GEAN) model to advance computational approaches for understanding the biological underpinnings of stress-related psychiatric disorders. The key objectives are to: 1) identify epigenetic markers and brain regions...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $715,662 to support research investigating the epigenetic mechanisms underlying stress vulnerability and its link to psychiatric disorders. The 5-year award to the University of Pennsylvania will employ genetic, genomic, molecular, and behavioral approaches to examine how chronic stress exposure impacts the transcription factor YY1 and related...
This Project Grant award from the National Institute of Mental Health (NIMH) under CFDA 93.242 Mental Health Research Grants provides $754,267 to Rutgers, The State University to conduct a hybrid effectiveness-implementation trial of massed prolonged exposure (M-PE) therapy for posttraumatic stress disorder (PTSD) in a community substance use treatment program. The primary aim is to compare the effectiveness of M-PE versus usual care in improving PTSD symptoms and substance use outcomes among...

This Project Grant award of $843,254, made by the National Institute of Mental Health (NIMH) under the Mental Health Research Grants (CFDA 93.242) program, supports research to fine-map robust genetic risk loci for post-traumatic stress disorder (PTSD) and identify associated molecular mechanisms and clinical phenotypes. The primary awardee, The Mclean Hospital Corporation, will collaborate with researchers at SUNY Downstate Health Sciences University and UC San Diego to: 1) identify causal variants and genes within PTSD risk loci and analyze region-specific gene expression, methylation, and protein networks; 2) investigate cell type-specific causal variants, genes, and molecular alterations associated with PTSD; and 3) characterize the phenomic impact of prioritized PTSD risk variants, genes, and networks, including exploring PTSD subtypes and polygenic risk scores. This research aims to enhance understanding of the multi-omic and multi-cell type brain mechanisms underlying PTSD development and pathophysiology, and point toward novel intervention targets.

Generated 4/8/25, 5:40 AM